Home / Recalls / Perrigo Company PLC / D-1016-2020

D-1016-2020 Class II Terminated

Recalled by Perrigo Company PLC — Allegan, MI

Recall Details

Product Type
Drugs
Report Date
March 25, 2020
Initiation Date
October 23, 2019
Termination Date
November 6, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity

Product Description

Regular Strength Acid Reducer, Ranitidine tablets, USP 75 mg, 160 tablets per bottle. [NDC: Brand] NDC CVS Health.: 69842-293-06

Reason for Recall

CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.

Distribution Pattern

Nationwide USA

Code Information

Lots: 8FE1455, 8GE1343, 8HE1225, 8KE2834, 8KE2249, 8ME2730, 9AE2838, 9EE2639, 9FE2993

Other recalls by Perrigo Company PLC

  • D-0596-2022 Class II — Acetaminophen Infant Dye Free Grape Oral Suspension (160mg/5ml), 2 FL OZ (59 mL) (October 26, 2021)
  • D-0595-2022 Class II — Acetaminophen Infant Dye Free Grape Oral Suspension (160mg/5ml), 2 FL OZ (59 mL) (October 26, 2021)
  • D-0600-2022 Class II — Children's Pain & Fever Acetaminophen, 160 mg per 5 mL Oral Suspension combo pac (October 26, 2021)
  • D-0581-2022 Class II — Children's Grape Flavored Acetaminophen Oral Suspension (160mg/5ml), 4 FL OZ (11 (October 26, 2021)
  • D-0579-2022 Class II — Acetaminophen Oral Suspension Grape Flavor, 160 mg per 5 mL, 16 fl oz (473 mL) p (October 26, 2021)
  • D-0616-2022 Class II — Maxiumum Strength No Drip Nasal Spray, Oxymetazoline HCl 0.05% Nasal Decongestan (October 26, 2021)
  • D-0621-2022 Class II — Maximum Strength No Drip Nasal Spray, Oxymetazoline HCl 0.05% Nasal Decongestant (October 26, 2021)
  • D-0609-2022 Class II — Severe Congestion Nasal Spray, No Drip Plus Menthol, Oxymetazoline HCl 0.05%, 1 (October 26, 2021)
  • D-0617-2022 Class II — Nasal Spray Decongestant, No Drip, Oxymetazoline HCl 0.05%, 1 FL Oz (30 mL) per (October 26, 2021)
  • D-0588-2022 Class II — Acetaminophen Child Dye Free Cherry Flavor Oral Suspension (160mg/5ml), 4 FL OZ (October 26, 2021)